Differential effects of [³H]nemonapride and [³H]spiperone binding on human dopamine D₄ receptorsHIDAKA, K; MATSUMOTO, M; TADA, S et al.Neuroscience letters. 1995, Vol 186, Num 2-3, pp 145-148, issn 0304-3940Article

A facile approach to trans-4,5-pyrrolidine lactam and application in the synthesis of nemonapride and streptopyrrolidineWEI HUANG; MA, Jing-Yi; MU YUAN et al.Tetrahedron (Oxford. Print). 2011, Vol 67, Num 40, issn 0040-4020, 7629, 7829-7837 [10 p.]Article

Effects of YM-43611, a novel dopamine D₂-Like receptor antagonist, on immediate early gene expression in the rat forebrainKUROKAWA, K; NARITA, M; KOSHIYA, K et al.Neuropsychopharmacology (New York, NY). 1997, Vol 17, Num 1, pp 27-33, issn 0893-133XConference Paper

In vivo binding of [¹¹C]nemonapride to sigma receptors in the cortex and cerebellumISHIWATA, K; SENDA, M.Nuclear medicine and biology. 1999, Vol 26, Num 6, pp 627-631, issn 0969-8051Article

High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detectionNAGASAKI, T; OHKUBO, T; SUGAWAR, K et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 714, Num 2, pp 293-298, issn 1387-2273Article

Effects of dopamine antagonists on changes in spontaneous EEG and locomotor activity in ketamine-treated ratsYAMAMOTO, M; MIZUKI, Y; SUETSUGI, M et al.Pharmacology, biochemistry and behavior. 1997, Vol 57, Num 1-2, pp 361-365, issn 0091-3057Article

Quantitative ex vivo and in vitro receptor autoradiography using ¹¹c-labeled ligands and an imaging plate : A study with a dopamine D₂-Like receptor ligand [¹¹C]nemonaprideISHIWATA, K; OGI, N; TANAKA, A et al.Nuclear medicine and biology. 1999, Vol 26, Num 3, pp 291-296, issn 0969-8051Article

Prolactin response to nemonapride, a selective antagonist for D₂ like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 geneMIHARA, K; KONDO, T; SUZUKI, A et al.Psychopharmacologia. 2000, Vol 149, Num 3, pp 246-250, issn 0033-3158Article

[³H]nemonapride and [³H]spiperone label equivalent numbers of D₂ and D₃ dopamine receptors in a range of tissues and under different conditionsVILE, J. M; D'SOUZA, U. M; STRANGE, P. G et al.Journal of neurochemistry. 1995, Vol 64, Num 2, pp 940-943, issn 0022-3042Article

Associations between side effects of nemonapride and plasma concentrations of the drug and prolactinKONDO, Tsuyoshi; ISHIDA, Masayuki; TOKINAGA, Noboru et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 2, pp 287-291, issn 0278-5846Article

Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactinKONDO, T; MIHARA, K; YASUI, N et al.Journal of clinical psychopharmacology. 2000, Vol 20, Num 4, pp 404-409, issn 0271-0749Article

General Entry to Asymmetric One-Pot [N + 2 + n] Cyclization for the Synthesis of Three- to Seven-Membered AzacycloalkanesHARADA, Shingo; SAKAI, Takeo; TAKASU, Kiyosei et al.Journal of organic chemistry. 2012, Vol 77, Num 17, pp 7212-7222, issn 0022-3263, 11 p.Article

3-Aminopyrrolidines from α-Aminoacids : Total Synthesis of (+)-Nemonapride from D-AlanineCAM THUY HOANG; VIET HOANG NGUYEN; ALEZRA, Valérie et al.Journal of organic chemistry. 2008, Vol 73, Num 3, pp 1162-1164, issn 0022-3263, 3 p.Article

Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D₂-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [¹¹C]raclopride, [¹¹C]nemonapride and [¹¹C]N-methylspiperoneISHIWATA, Kiichi; OGI, Nobuo; HAYAKAWA, Nobutaka et al.Nuclear medicine and biology. 2002, Vol 29, Num 3, pp 307-316, issn 0969-8051Article

No relationship between - 141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary studyMIHARA, Kazuo; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Psychiatry research. 2001, Vol 101, Num 1, pp 33-38, issn 0165-1781Article

The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT_1A receptor agonist propertiesPRINSSEN, E. P. M; KLEVEN, M. S; KOEK, W et al.European journal of pharmacology. 1998, Vol 356, Num 2-3, pp 189-192, issn 0014-2999Article

Potent activation of dopamine D₃/D₂ heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropiniroleMAGGIO, Roberto; SCARSELLI, Marco; NOVI, Francesca et al.Journal of neurochemistry. 2003, Vol 87, Num 3, pp 631-641, issn 0022-3042, 11 p.Article

Brain σ receptors labelled by [³H]nemonaprideHELMESTE, D; TANG, S. W; FANG, H et al.European journal of pharmacology. 1996, Vol 301, Num 1-3, pp R1-R3, issn 0014-2999Article

Effects of sulpiride and nemonapride, benzamide derivatives having distinct potencies of antagonistic action on dopamine D₂ receptors, on sensitization to methamphetamine in miceKURIBARA, H.Journal of pharmacy and pharmacology. 1996, Vol 48, Num 3, pp 292-296, issn 0022-3573Article